Jason Hulse Murray is the co-founder, CEO and chairman of PACS Group, Inc.. His Form 4 filing, a report of an insider's stock transactions, was filed on Nov. 9, 2026. The sales took place on Nov. 5, four days before the filing date.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-05 |
| Date of Latest Transaction | 2026-11-05 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 19,235 |
| Price | $50.64 |
| Total Transaction Value | $974,027.43 |
| Insider | |
| Ticker Symbol | PACS |
| Company | PACS Group, Inc. |
| Insider Name | Murray Jason Hulse |
| Insider Title | Co-Founder, CEO & Chairman |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 53,934,866 |
| Position Size Change | 0.04% |
| Filing | |
| Filing Date | 2026-11-09 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were stock sales, reported under SEC transaction code S. One filing covers two sale transactions by the same insider.
What was the average price of the transaction?
The average price across the two sales was $50.64 per share, rounded to cents. The available details do not list a separate price for each sale.
How did this transaction affect the insider's holdings?
The sales reduced his reported holdings by 19,235 shares, leaving 53,934,866 shares owned afterward. The shares sold made up about 0.04% of his reported holdings before the sales.
What's the total transaction value?
The total value was $974,027.43 for both sales combined, rounded to cents. This covers all 19,235 shares sold in the two transactions.
Are there any special circumstances around this transaction?
The filing information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Without footnote text, the plan's coverage of each sale cannot be confirmed. Its start date, terms and trading schedule are unknown.
For research purposes only; not investment advice.